Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
New York Genome Center | RCV001839083 | SCV002098984 | uncertain significance | Spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits | 2021-03-13 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003546731 | SCV004267363 | uncertain significance | not provided | 2023-08-30 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with cysteine, which is neutral and slightly polar, at codon 2320 of the CACNA1G protein (p.Gly2320Cys). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on CACNA1G protein function. ClinVar contains an entry for this variant (Variation ID: 1342332). This missense change has been observed in individual(s) with clinical features of CACNA1G-related conditions (PMID: 34248568). This variant is present in population databases (rs760308715, gnomAD 0.03%). |